PODCAST

Pulmonary Medicine

ReachMD

science & medicine medicine

All Episodes

00:00:00

Behind the Scenes of the Johns Hopkins Coronavirus...

Pulmonary Medicine ·

2020/04/23

Host: Joshua Sharfstein, MD Guest: Beth Blauer The COVID-19 dashboard run by the Johns Hopkins Center for Systems Science and Engineering has been a critical source of near real-time tracking of the spread of the novel coronavirus since it first emerged. Beth Blauer, Executive Director of Centers for Civic Impact and an expert on the public’s use of data and analytics, is part of the team that manages the map. Blauer talks to Dr. Josh Sharfstein about how the global dashboard

00:00:00

HHS Approves Pharmacy COVID-19 Testing & Sets Testing...

Pulmonary Medicine ·

2020/04/21

Host: Linda Bernstein, Pharm.D. Join pharmacist Dr. Linda Bernstein as she outlines the United States Health and Human Services’ authorization of licensed pharmacists to order and administer FDA-approved COVID-19 tests as well as the priority patient testing categories as set forth by the U.S. Public Health Service. Published April 21, 2020

00:00:00

Novel Therapeutic & Prevention Approaches to the...

Pulmonary Medicine ·

2020/04/21

Host: Linda Bernstein, Pharm.D. Tune in as pharmacist Dr. Linda Bernstein looks at a few of the novel approaches researchers all over the world are taking to conquer the novel coronavirus in addition to evaluating what these approaches may mean for today and potential viral mutations going forward. Published April 21, 2020

00:00:00

Drug Shortages During the COVID-19 Pandemic

Pulmonary Medicine ·

2020/04/21

Host: Linda Bernstein, Pharm.D. Critical medicine shortages during the COVID-19 pandemic, particularly for drugs required to support patients on mechanical ventilation, is the focus of this episode of The Drug Report. Pharmacist Dr. Linda Bernstein describes the urgent appeals made by major healthcare organizations, related reports highlighting the serious impact of these shortages on fill rates for critical medicines, and progress being made at the federal level to remedy the

00:00:00

CDC Guidance for Pharmacy Staff on Minimizing...

Pulmonary Medicine ·

2020/04/17

Host: Linda Bernstein, Pharm.D. The Centers for Disease Control provided a guidance for pharmacy staff to minimize their risk of exposure to the COVID-19 virus and reduce customer risk during the pandemic. Pharmacist Dr. Linda Bernstein presents highlights of the guidance that offers recommendations on ways to minimize viral exposure when medication dispensing along with methods to minimize patient-to-patient contact. Published on April 17, 2020

00:00:00

A Guide for Off-Label Use of Treatments for COVID-19...

Pulmonary Medicine ·

2020/04/17

Host: Linda Bernstein, Pharm.D. The American Society of Health Systems Pharmacists (ASHP) recently published recommendations for prescribers, pharmacists and patients when considering the proper use of experimental treatments during the COVID-19 pandemic. Inappropriate prescribing of experimental treatments “just in case” or for patients not at high risk of severe illness may lead to insufficient supplies of critical medicines that are needed to treat other patients who depend on these

00:00:00

Uncovering COVID-19 Treatments: An Update on the...

Pulmonary Medicine ·

2020/04/17

Host: Linda Bernstein, Pharm.D. The World Health Organization (WHO) and partners recently announced it was launching an international clinical trial with the goal of generating significant worldwide data from thousands of patients to find the most effective treatments for COVID-19. Pharmacist Dr. Linda Bernstein brings you an update on the WHO SOLIDARITY trial, which will offer clinicians simplified procedures to enable even overloaded hospitals to participate. Published April 17,

00:00:00

Renin-Angiotensin-Aldosterone System Inhibitors in...

Pulmonary Medicine ·

2020/04/17

Host: Linda Bernstein, Pharm.D. Pharmacist Dr. Linda Bernstein highlights the key points of a New England Journal of Medicine article that given the available evidence, the authors and multiple specialty medical societies believe that—despite theoretical concerns and uncertainty pertaining to the effect of RAAS inhibitors on ACE2 and its potential relationship to COVID-19 severity—RAAS inhibitors should be continued in patients who are otherwise in stable condition who are at risk for

00:00:00

REMS-Required Drug Monitoring During the COVID-19...

Pulmonary Medicine ·

2020/04/17

Host: Linda Bernstein, Pharm.D. The Food and Drug Administration has issued a guidance on its temporary policy for certain risk evaluation and mitigation strategies (REMS) requirements during the COVID-19 pandemic that include laboratory monitoring and imaging studies. Pharmacist Dr. Linda Bernstein discusses the guidance and its impact on patient access to certain REMS drugs when patients self-isolate or are subject to quarantine due to COVID-19. Published April 17, 2020

00:00:00

Historian John Barry on COVID-19

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Guest: Paul B. Spiegel, MD Guest: John Barry The historical context of 1918 shaped much of the response to the flu pandemic in the US—just as it will with COVID-19. Dr. Paul Spiegel, director of the Center for Humanitarian Health, talks with historian and author John Barry about how an absence of credible leadership and messaging hindered response efforts then and what lessons we can apply today. Published April 13, 2020

00:00:00

Amesh Adalja, Infectious Disease Expert, Answers Your...

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Guest: Amesh Adalja, MD What did we learn this week? Is there a connection between 5G cell phone towers and the novel coronavirus? How often should you wash a homemade cloth mask? Is there any truth behind using hydroxychloroquine as a treatment? Will people on ventilators have permanent lung damage? What’s it like for doctors and nurses in the hospitals right now? Dr. Amesh Adaljaof the Johns Hopkins Center for Health Security addresses your questions

00:00:00

When Will We Get a COVID-19 Vaccine?

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Host: Stephanie Desmon Guest: William J. Moss, MD Development of a COVID-19 vaccine is an essential part of halting the pandemic. But will it be months or years before we see one? Vaccine expert Dr. William Moss talks to Stephanie Desmon about the complexities of vaccine development and manufacturing, potential hold ups, how opponents of vaccination may come into play, and why COVID-19 may threaten current immunization programs. Published April 10,

00:00:00

Baltimore’s Grassroots Effort to Provide Mental...

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Guest: Amy Greensfelder, MSW Guest: Shantay Jackson Fallout from COVID-19 goes beyond case counts—we are facing “an epidemic of isolation and loneliness,” says Councilman Zeke Cohen. The Baltimore Neighbors Network is a virtual community of trained volunteers who are available to listen to city residents and provide resources for follow-up if needed. Councilman Cohen, Shantay Jackson, executive director of the Baltimore Community Mediation Center,

00:00:00

Former CDC Director Tom Frieden on What We Need to Do...

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Host: Stephanie Desmon Guest: Tom Frieden What will need to happen for businesses and schools to reopen, and what might the future look like with COVID-19? Former CDC director Tom Frieden talks to Stephanie Desmon about what governments and individuals should be doing right now to help curb the spread of the virus and move America closer to reopening. Published April 9, 2020

00:00:00

COVID-19 & the Law

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Guest: Lainie Rutkow, PhD, JD There have been varying responses to COVID-19 carried out across local, state, and federal governments in the US. But what powers does the government have at various levels in a pandemic and how does the law work when an enemy like COVID-19 “does not respect jurisdictional boundaries?” Law expert and Hopkins professor Dr. Lainie Rutkow talks to Dr. Josh Sharfstein about a range of legal issues, including what happens if

00:00:00

A Nurse’s Perspective on Testing Capacity & Mask...

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Host: Stephanie Desmon Guest: Jason E. Farley, PHD, MSN, MPH, RN Why was the US slow to stand up testing and is this improving? Should you wear a cloth mask in your daily activities? Jason Farley, an infectious disease-trained nurse epidemiologist at the Johns Hopkins School of Nursing, talks to Stephanie Desmon and breaks down the complications of testing for COVID-19 and why recommendations on the public’s use of masks may be evolving. Published

00:00:00

What the US Can Learn from Singapore’s COVID-19 Response

Pulmonary Medicine ·

2020/04/16

Host: Joshua Sharfstein, MD Guest: Vernon Lee, PhD Early on in the COVID-19 outbreak, Singapore quickly launched a robust response which included widespread testing, diligent contact tracing and quarantining, and isolation of all sick persons, even those with mild symptoms. Alumnus Dr. Vernon Lee, Director of Communicable Diseases at the Ministry of Health of Singapore, talks to Dr. Josh Sharfstein about how lessons from the 2003 SARS outbreak informed Singapore’s risk-based

00:00:00

Are Men More Susceptible to COVID-19?

Pulmonary Medicine ·

2020/04/10

Host: Joshua Sharfstein, MD Guest: Sabra L. Klein, PhD Host: Stephanie Desmon Guest: Rosemary Morgan, PhD Globally, more men are dying from COVID-19 than women. But is this due to sex (biological differences), gender (social and contextual differences), or something else entirely? Stephanie Desmon talks to virologist Sabra Klein and social scientist Rosemary Morgan about risk factors associated with COVID-19. Published April 6, 2020

00:00:00

Lessons from Liberia: What the US Can Learn from the...

Pulmonary Medicine ·

2020/04/10

Host: Joshua Sharfstein, MD Guest: Tolbert G. Nyenswah, MPH In 2014, Tolbert Nyenswah, then an assistant minister of health in Liberia, was tapped to lead the nation’s response to the Ebola epidemic. Under his leadership, an Incident Management System deployed thousands of epidemiologists, case managers, and contact tracers in a technical response that brought the outbreak under control. Nyenswah talks to Dr. Josh Sharfstein about what the US can learn from Liberia’s experience and

00:00:00

COVID-19 & the Potential for Prescription Drug Shortages

Pulmonary Medicine ·

2020/04/10

Host: Joshua Sharfstein, MD Guest: Howard Sklamberg What does a global pandemic mean for the world’s drug supply chain? Howard Sklamberg, lawyer and former FDA deputy commissioner, talks to Dr. Josh Sharfstein about the threats that COVID-19 poses to medications for everything from cancer to diabetes to hypertension. Published April 3, 2020

242 results

Pulmonary Medicine

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事